Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CALCITONIN SALMON for Hyperparathyroidism primary: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where CALCITONIN SALMON was used for Hyperparathyroidism primary.

Most Reported Side Effects for CALCITONIN SALMON

Side Effect Reports % Deaths Hosp.
Drug ineffective 103 17.1% 2 58
Product dose omission issue 48 8.0% 0 1
Nausea 45 7.5% 2 9
Off label use 37 6.2% 0 17
Vomiting 36 6.0% 1 11
Product delivery mechanism issue 33 5.5% 0 0
Dizziness 30 5.0% 0 4
Product odour abnormal 27 4.5% 0 0
Epistaxis 26 4.3% 0 0
Hypercalcaemia 26 4.3% 5 15
Headache 24 4.0% 0 3
Foetal exposure during pregnancy 23 3.8% 0 7
Disease progression 21 3.5% 2 2
Dyspnoea 20 3.3% 1 4
Maternal exposure during pregnancy 20 3.3% 0 5

Other Indications for CALCITONIN SALMON

Product used for unknown indication (162) Osteoporosis (123) Hypercalcaemia (109) Bone giant cell tumour benign (17) Osteopenia (14) Complex regional pain syndrome (12) Bone disorder (11) Hypercalcaemia of malignancy (8) Foetal exposure during pregnancy (7) Bone density decreased (6)

Other Drugs Used for Hyperparathyroidism primary

CINACALCET (510) DENOSUMAB (86) CALCITONIN (15) SENSIPAR (14) FUROSEMIDE (11) ZOLEDRONIC ACID (10) EVOCALCET (6) MIMPARA (6) SODIUM (5)

Related Pages

CALCITONIN SALMON Full Profile All Hyperparathyroidism primary Drugs CALCITONIN SALMON Demographics CALCITONIN SALMON Timeline